Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cardinal to Buy Harvard Drug Group for $1.12 Billion
Cardinal to Buy Harvard Drug Group for $1.12 Billion
Cardinal to Buy Harvard Drug Group for $1.12 Billion
Submitted by
admin
on June 5, 2015 - 9:09am
Source:
Bloomberg
News Tags:
Cardinal Health
M&A
Harvard Drug Group
generics
Headline:
Cardinal to Buy Harvard Drug Group for $1.12 Billion
Do Not Allow Advertisers to Use My Personal information
